The Intelence aNd pRezista Once A Day Study (INROADS): a multicentre, single‐arm, open‐label study of etravirine and darunavir/ritonavir as dual therapy in HIV‐1‐infected early treatment‐experienced subjects

Publisher: John Wiley & Sons Inc

E-ISSN: 1468-1293|16|5|288-296

ISSN: 1464-2662

Source: HIV MEDICINE, Vol.16, Iss.5, 2015-05, pp. : 288-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content